Patents Assigned to Phenix Pharmaceuticals AG
  • NR1H4 nuclear receptor binding compounds
    Patent number: 6974830
    Abstract: The present invention relates to compounds according to the general formula (I) which bind to the NR1H4 receptor and act as agonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds and the production of medicaments using the compounds.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: December 13, 2005
    Assignee: Phenix Pharmaceuticals AG
    Inventors: Ulrike Bauer, Zach Cheruvallath, Ulrich Deuschle, Elena Dneprovskaia, Tim Gahman, Kristina Giegrich, Ronnie Hanecak, Normand Hébert, John Kiely, Ingo Kober, Manfred Kögl, Harald Kranz, Claus Kremoser, Matthew Lee, Kerstin Otte, Carlton Sage, Manish Sud